Some genetic characteristics of sabin-like poliovirus isolated from acute flaccid paralysis cases in Nigeria

African Journal of Biotechnology

Volumn 2, Issue 11, 2003, Pages 509-515

  Adu, Festus Doyin ^a   Iber, Jane ^b   Harry, Tekena ^c   Burns, Cara ^b   Oyedele, Oluseyi ^a   Adeniji, Johnson Adekunle ^a   Ossei Kwasi, Mubarak ^d   Kilpatrick, David ^b   Tomori, Oyewale ^e   Kew, Olen ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF MAIDUGURI   (Nigeria)

^d University of Ghana   (Ghana)

^e WHO Regional Office for Africa   (Zimbabwe)

Author keywords

Crossover; Genome; Nigeria; Non polio enterovirus; Poliovirus; Recombination; Sabin like; Sequence; Vaccine

Indexed keywords

NUCLEOTIDE;

ACUTE DISEASE; ARTICLE; CIRCULATING VACCINE DERIVED POLIOVIRUS; CONTROLLED STUDY; FLACCID PARALYSIS; GENETIC RECOMBINATION; GENETIC SCREENING; GENETIC TRAIT; GENOME; IMMUNIZATION; NIGERIA; NONHUMAN; POLIOMYELITIS VIRUS; SABIN LIKE POLIOVIRUS; SEQUENCE ANALYSIS; SEROTYPE; VIRAL GENETICS; VIRUS CAPSID; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TYPING;

ENTEROVIRUS; POLIOVIRUS;

EID: 3042645190     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alexander JP Jr, Gay HE Jr, Pallansch MA (1997). Duration of poliovirus excretion and its importance for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis.175 (Suppl. 1): S176-S182. [Pubmed]
2. Bellmunt AG, May R, Pring-Akerblom ZP, Verhgen W, Heim A (1999). Evolution of polio virus type 1 during 5.5 years of prolonged enteral replication in an immunodefficient patient. Virology 265: 178-184. [Pubmed]
3. De L, Yang C-F, da Silva E (1997). Genotypic specific RNA probes for direct identification of wild polio viruses by blot hybridization. J. Clin. Microbiol. 35:2834-2840. [Pubmed]
4. Felsentein J (1981). Evolutionary trees form DNA sequences - a maximum likelihood approach. J. Mol. Evol. 17:368-376. [Pubmed]
5. Felsentein J. (1993). PHYLIP (phylogeny inference package version 3.5c. University of Washington, Dept of Genetics.
6. Fine PE, Carneiro IA (1999). Transmissibility and persistence of oral polio vaccine viruses: implication for global poliomyelitis eradication initiatives. Am. J. Epidemiol. 150:1001-1021. [Pubmed]
7. Georgescu MM, Depeyroux F, Tardy-Panit M, Ballanant J, Contriescu M, Conbriescu AA, Gulliot S, Crainic R (1994). High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 68:8089-8101. [Pubmed]
8. Georgescu NM, Delpeyroux F, Crainic R (1995). Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant polio virus. J. Gen. Virol.76: 2343-2348. [Pubmed]
9. Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA (1995). Molecular epidemiology of polioviruses. Semin. Virol. 6: 401-414.
10. Kew OM, Sutter RW, Nottay B, McDonought M, Prevots DR, Quick L, Pallansch M (1998). Prolonged replication of type 1 vaccine-derived poliovirus in an immunodefficient patent. J. Clin. Microbiol. 36: 2893-2899. [Pubmed]
11. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, Andre J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, van Der Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C (2002). Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived polio virus. Science 296:356-359. [Pubmed]
12. Kilpatrick DR, Nottay B, Yang C-F, Yang S-J, da Silva E. (1998). Serotype specific identification of polio viruses by PCR using primers containing mixed base or Deoxyinosine residues at position of codon degeneracy. J. Clin. Microbiol. 36: 352-357. [Pubmed]
13. Lipaskaya GY, Muzychenko AR, Kutitova OK, Maslova SV, Equstre M, Drozdov SG, Perez- Bercoff R, Agol VI (1991). Frequent isolation of intertypic poliovirus recombinant with serotype 2 specificity from vaccine-associated polio cases. J. Med. Virol. 35:290-296. [Pubmed]
14. Liu HM, Zheng DP, Zhang LB, Oberste MS, Pallansch MA, Kew OM (2000). Molecular evolution of type 1 wild-vaccine virus recombinant during widespread circulation in China . J. Virol. 74: 11153-11161. [Pubmed]
15. Macadam AJ, Polland SR, Ferguson G (1993). Genetic basis of attenuation of Sabin type 2 vaccine strain of polio virus in primates. Virology 192:18-26. [Pubmed]
16. Martin J, Dunn G, Hull R, Patel V, Minor PD (2000). Evolution of the Sabin strain of type 3 polio virus in an immunodefficient patient during the entire 637-day period of virus excretion. Virology 74:3001-3010. [Pubmed]
17. Minor PD, Dunn G (1988). The effect of sequences in the 51 non-coding region of the replication of polio virus in human gut. J. Gen. Virol. 69: 1091-1096. [Pubmed]
18. Saitou N, Mei N (1987). The neighbour-joining method - a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4: 406-425. [Pubmed]
19. van der Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM (1995). Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 33: 2562-2566. [Pubmed]
20. World Health Organization (2002). Polio: Report of he Interim Meeting of the Technical ConsultationGroupon the Global Eradicationof Poliomyelitis. WHO/EPI/GEN/02. World Health Organization, Geneva.
21. World Health Organization (2002). Progress towards the global eradication of poliomyelitis. Wkly Epid. Rep. 787:98-107. [Pubmed]
22. World Health Organization (March 2003). WHO Nigerian Monthly Bulletin of Vaccine Preventable Diseases. Vol. 2No3. World Health Organization, Lagos, Nigeria.
23. World Health Organization (2002). WHO Nigerian Monthly Bulletin of Vaccine Preventable Diseases. Vol No2. World Health Organization, Lagos, Nigeria.
24. World Health Organization (2002). Manual for the virologic investigation of poliomyelitis. WHO/EPI/GEN/02.1. World Health Organization. Geneva.
25. Yang C-F, De L, Holloway BP, Pallansch MA, Kew OM (1991). Detection and identification of vaccine related polioviruses by the polymerase chain reaction. Virus Res. 20: 159-179. [Pubmed]